Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-27T09:01:38.438Z Has data issue: false hasContentIssue false
  • English
  • Français

Risperidone-induced leucopenia and neutropenia

Published online by Cambridge University Press:  03 January 2018

Z. Dernovsek  and
R. Tavcar
Z. Dernovsek
Affiliation:
Medical Centre, Department of Psychiatry, Studenec 48, S1-1260 Ljubljana-Polje, Slovenia
R. Tavcar
Affiliation:
Medical Centre, Department of Psychiatry, Studenec 48, S1-1260 Ljubljana-Polje, Slovenia
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 171 , Issue 4 , October 1997 , pp. 393 - 394
Copyright
Copyright © 1997 The Royal College of Psychiatrists 

References

Bondolfi, G., Morona, P., Dascal, D. R., et al (1996) Risperidone and reversible neutropenia: a negative rechallenge. European Neuropsychopharmacobgy, 6, 257.Google Scholar
Curtis, V. A. & Kerwin, R. W. (1995) A risk–benefit assessment of risperidone in schizophrenia. Drug Safety, 12, 139–145.CrossRefGoogle ScholarPubMed
Godleski, L. S. & Sernyak, M. J. (1996) Agranulocytosis after addition of risperidone to clozapine treatment. American Journal of Psychiatry, 153, 735–736.Google Scholar
Mahmood, T., Silverstone, T. & Spittle, B. (1996) Risperidone appears safe in patients with antipsychotic-induced blood dyscrasias. International Clinical Psychophormacology, II, 53–54.Google Scholar
Meylan, C., Bondolfi, G., Aubert, A. C., et al (1995) Reversible neutropenia during a cold: possible involvement of risperidone? A case report. European Neuropsychopharmocology, 5, 1–3.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.